MASC 2022: What challenges and opportunities do supramolecular chemists face in coming years? (2022)

First Author: Pilgrim B
Attributed to:  Repurposing and/or reactivating disused clinically relevant medical therapies funded by FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrp.2022.101199

Publication URI: http://dx.doi.org/10.1016/j.xcrp.2022.101199

Type: Journal Article/Review

Parent Publication: Cell Reports Physical Science

Issue: 12